Improving the Predictive Quality of CoMFA Models

[1]  L. E. Chirlian,et al.  Atomic charges derived from electrostatic potentials: A detailed study , 1987 .

[2]  P Riederer,et al.  Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding site. , 1998, Journal of medicinal chemistry.

[3]  Matthew Clark,et al.  The Probability of Chance Correlation Using Partial Least Squares (PLS) , 1993 .

[4]  R T Kroemer,et al.  Comparative molecular field analysis of haptens docked to the multispecific antibody IgE(Lb4) , 1996, Journal of medicinal chemistry.

[5]  Ettore Novellino,et al.  Comparative Molecular Field Analysis on a Set of Muscarinic Agonists , 1991 .

[6]  H. Weber,et al.  Experience with comparative molecular field analysis , 1993 .

[7]  G. Cruciani,et al.  Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .

[8]  G Klebe,et al.  On the prediction of binding properties of drug molecules by comparative molecular field analysis. , 1993, Journal of medicinal chemistry.

[9]  P. Geladi.  Notes on the history and nature of partial least squares (PLS) modelling , 1988 .

[10]  Johann Gasteiger,et al.  Multivariate structure‐activity relationships between data from a battery of biological tests and an ensemble of structure descriptors: The PLS method , 1984 .

[11]  Glen Eugene Kellogg,et al.  HINT: A new method of empirical hydrophobic field calculation for CoMFA , 1991, J. Comput. Aided Mol. Des..

[12]  H. V. Gelder.  The Netherlands , 2004, Constitutions of Europe (2 vols.).

[13]  Yvonne C. Martin,et al.  A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists , 1993, J. Comput. Aided Mol. Des..

[14]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[15]  A. Hopfinger.  Computer-assisted drug design. , 1985, Journal of medicinal chemistry.

[16]  R. S. Mulliken.  Electronic Population Analysis on LCAO–MO Molecular Wave Functions. I , 1955 .

[17]  K. Liedl,et al.  Different electrostatic descriptors in comparative molecular field analysis: A comparison of molecular electrostatic and coulomb potentials , 1996, J. Comput. Chem..

[18]  W. Welsh,et al.  A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors. , 1996, Journal of medicinal chemistry.

[19]  C. Breneman,et al.  Determining atom‐centered monopoles from molecular electrostatic potentials. The need for high sampling density in formamide conformational analysis , 1990 .

[20]  A. Debnath,et al.  Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1. , 1994, Journal of medicinal chemistry.

[21]  D. E. Patterson,et al.  Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies , 1988 .

[22]  Mario Marsili,et al.  Generation and comparison of space-filling molecular models , 1983, Comput. Chem..

[23]  Y. Martin,et al.  Direct prediction of dissociation constants (pKa's) of clonidine-like imidazolines, 2-substituted imidazoles, and 1-methyl-2-substituted-imidazoles from 3D structures using a comparative molecular field analysis (CoMFA) approach. , 1991, Journal of medicinal chemistry.

[24]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[25]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[26]  S. Wold.  Cross-Validatory Estimation of the Number of Components in Factor and Principal Components Models , 1978 .

[27]  P. Ettmayer,et al.  3D-quantitative structure-activity relationships of human immunodeficiency virus type-1 proteinase inhibitors: comparative molecular field analysis of 2-heterosubstituted statine derivatives-implications for the design of novel inhibitors. , 1995, Journal of medicinal chemistry.

[28]  S. Wold,et al.  Multivariate Data Analysis in Chemistry , 1984 .

[29]  Romano T. Kroemer,et al.  Replacement of steric 6–12 potential-derived interaction energies by atom-based indicator variables in CoMFA leads to models of higher consistency , 1995, J. Comput. Aided Mol. Des..

[30]  P. Kollman,et al.  An approach to computing electrostatic charges for molecules , 1984 .

[31]  J. Stewart.  Optimization of parameters for semiempirical methods I. Method , 1989 .

[32]  David A. Frenkel,et al.  CoMFA validation of the superposition of six classes of compounds which block GABA receptors non-competitively , 1993, J. Comput. Aided Mol. Des..

[33]  D. Goodsell,et al.  Automated docking of substrates to proteins by simulated annealing , 1990, Proteins.

[34]  K F Koehler,et al.  Predictive binding of beta-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach. , 1992, Journal of medicinal chemistry.

[35]  W. Milhous,et al.  Structure-activity relationships of the antimalarial agent artemisinin. 1. Synthesis and comparative molecular field analysis of C-9 analogs of artemisinin and 10-deoxoartemisinin. , 1993, Journal of medicinal chemistry.

[36]  K F Koehler,et al.  Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site. , 1990, Journal of medicinal chemistry.

[37]  Ronan Bureau,et al.  Comparative molecular field analysis of CCK-A antagonists using field-fit as an alignment technique. A convenient guide to design new CCK-A ligands , 1992, J. Comput. Aided Mol. Des..

[38]  Henry S. Rzepa,et al.  Ground states of molecules: Part XLII. Vibrational frequencies of isotopically-substituted molecules calculated using MINDO/3 force constants , 1977 .

[39]  P. Kollman,et al.  Atomic charges derived from semiempirical methods , 1990 .

[40]  M. Dewar,et al.  Ground States of Molecules. 38. The MNDO Method. Approximations and Parameters , 1977 .

[41]  Romano T. Kroemer,et al.  A new procedure for improving the predictiveness of CoMFA models and its application to a set of dihydrofolate reductase inhibitors , 1995, J. Comput. Aided Mol. Des..

[42]  F I Carroll,et al.  Synthesis, ligand binding, and QSAR (CoMFA and classical) study of 3 beta-(3'-substituted phenyl)-, 3 beta-(4'-substituted phenyl)-, and 3 beta-(3',4'-disubstituted phenyl)tropane-2 beta-carboxylic acid methyl esters. , 1994, Journal of medicinal chemistry.

[43]  Gerhard Klebe,et al.  Recommendations for CoMFA Studies and 3D QSAR Publications , 1994 .

[44]  C Silipo,et al.  Correlation analysis. Its application to the structure-activity relationship of triazines inhibiting dihydrofolate reductase. , 1975, Journal of the American Chemical Society.

[45]  Garland R. Marshall,et al.  The Conformational Parameter in Drug Design: The Active Analog Approach , 1979 .